nodes	percent_of_prediction	percent_of_DWPC	metapath
Alosetron—CYP2C9—Capecitabine—stomach cancer	0.0903	0.326	CbGbCtD
Alosetron—HTR3A—myenteric nerve plexus—stomach cancer	0.0617	0.409	CbGeAlD
Alosetron—CYP1A2—Fluorouracil—stomach cancer	0.0594	0.214	CbGbCtD
Alosetron—CYP2C9—Fluorouracil—stomach cancer	0.0535	0.193	CbGbCtD
Alosetron—HTR3A—vagus nerve—stomach cancer	0.0411	0.273	CbGeAlD
Alosetron—CYP3A4—Irinotecan—stomach cancer	0.0324	0.117	CbGbCtD
Alosetron—CYP3A4—Docetaxel—stomach cancer	0.0238	0.0858	CbGbCtD
Alosetron—CYP3A4—Doxorubicin—stomach cancer	0.0177	0.0639	CbGbCtD
Alosetron—Ondansetron—HTR1A—stomach cancer	0.00871	1	CrCbGaD
Alosetron—HTR3A—hematopoietic system—stomach cancer	0.00672	0.0445	CbGeAlD
Alosetron—HTR3A—digestive system—stomach cancer	0.00467	0.0309	CbGeAlD
Alosetron—CYP1A2—hematopoietic system—stomach cancer	0.00347	0.023	CbGeAlD
Alosetron—CYP2C9—hematopoietic system—stomach cancer	0.00329	0.0218	CbGeAlD
Alosetron—CYP2E1—hematopoietic system—stomach cancer	0.00312	0.0207	CbGeAlD
Alosetron—CYP3A4—hematopoietic system—stomach cancer	0.00251	0.0166	CbGeAlD
Alosetron—CYP1A2—digestive system—stomach cancer	0.00241	0.016	CbGeAlD
Alosetron—CYP2C9—digestive system—stomach cancer	0.00229	0.0152	CbGeAlD
Alosetron—CYP2E1—lymphoid tissue—stomach cancer	0.0022	0.0145	CbGeAlD
Alosetron—CYP2E1—digestive system—stomach cancer	0.00217	0.0144	CbGeAlD
Alosetron—CYP1A2—endocrine gland—stomach cancer	0.00199	0.0132	CbGeAlD
Alosetron—CYP2C9—endocrine gland—stomach cancer	0.00189	0.0125	CbGeAlD
Alosetron—CYP1A2—liver—stomach cancer	0.0018	0.0119	CbGeAlD
Alosetron—CYP2E1—endocrine gland—stomach cancer	0.00179	0.0119	CbGeAlD
Alosetron—CYP3A4—digestive system—stomach cancer	0.00174	0.0116	CbGeAlD
Alosetron—CYP2C9—liver—stomach cancer	0.0017	0.0113	CbGeAlD
Alosetron—CYP2E1—liver—stomach cancer	0.00162	0.0107	CbGeAlD
Alosetron—CYP3A4—endocrine gland—stomach cancer	0.00144	0.00955	CbGeAlD
Alosetron—CYP3A4—liver—stomach cancer	0.0013	0.00861	CbGeAlD
Alosetron—Cystitis noninfective—Epirubicin—stomach cancer	0.00102	0.00193	CcSEcCtD
Alosetron—Cramp muscle—Docetaxel—stomach cancer	0.00101	0.00191	CcSEcCtD
Alosetron—Urine output increased—Methotrexate—stomach cancer	0.00101	0.00191	CcSEcCtD
Alosetron—Bladder pain—Methotrexate—stomach cancer	0.00101	0.00191	CcSEcCtD
Alosetron—Bone pain—Doxorubicin—stomach cancer	0.00101	0.00191	CcSEcCtD
Alosetron—Cystitis—Epirubicin—stomach cancer	0.00101	0.00191	CcSEcCtD
Alosetron—Nasopharyngitis—Docetaxel—stomach cancer	0.001	0.0019	CcSEcCtD
Alosetron—Arrhythmia—Irinotecan—stomach cancer	0.001	0.0019	CcSEcCtD
Alosetron—Colitis—Epirubicin—stomach cancer	0.001	0.0019	CcSEcCtD
Alosetron—Alopecia—Irinotecan—stomach cancer	0.000994	0.00188	CcSEcCtD
Alosetron—Abdominal pain upper—Capecitabine—stomach cancer	0.000993	0.00188	CcSEcCtD
Alosetron—Alanine aminotransferase increased—Docetaxel—stomach cancer	0.000991	0.00187	CcSEcCtD
Alosetron—Nasopharyngitis—Capecitabine—stomach cancer	0.000973	0.00184	CcSEcCtD
Alosetron—Flatulence—Irinotecan—stomach cancer	0.000964	0.00182	CcSEcCtD
Alosetron—Gastritis—Capecitabine—stomach cancer	0.000963	0.00182	CcSEcCtD
Alosetron—Arrhythmia—Fluorouracil—stomach cancer	0.000962	0.00182	CcSEcCtD
Alosetron—Alanine aminotransferase increased—Capecitabine—stomach cancer	0.000959	0.00181	CcSEcCtD
Alosetron—Abnormal dreams—Doxorubicin—stomach cancer	0.000955	0.00181	CcSEcCtD
Alosetron—Alopecia—Fluorouracil—stomach cancer	0.000952	0.0018	CcSEcCtD
Alosetron—Abdominal distension—Capecitabine—stomach cancer	0.000946	0.00179	CcSEcCtD
Alosetron—Bladder pain—Epirubicin—stomach cancer	0.000944	0.00178	CcSEcCtD
Alosetron—Cystitis noninfective—Doxorubicin—stomach cancer	0.000944	0.00178	CcSEcCtD
Alosetron—Muscle spasms—Irinotecan—stomach cancer	0.000941	0.00178	CcSEcCtD
Alosetron—Cystitis—Doxorubicin—stomach cancer	0.000933	0.00176	CcSEcCtD
Alosetron—Colitis—Doxorubicin—stomach cancer	0.000927	0.00175	CcSEcCtD
Alosetron—Polyuria—Methotrexate—stomach cancer	0.000922	0.00174	CcSEcCtD
Alosetron—Ill-defined disorder—Irinotecan—stomach cancer	0.000908	0.00172	CcSEcCtD
Alosetron—Abdominal discomfort—Capecitabine—stomach cancer	0.000901	0.0017	CcSEcCtD
Alosetron—Malaise—Irinotecan—stomach cancer	0.000883	0.00167	CcSEcCtD
Alosetron—Upper respiratory tract infection—Capecitabine—stomach cancer	0.000874	0.00165	CcSEcCtD
Alosetron—Bladder pain—Doxorubicin—stomach cancer	0.000873	0.00165	CcSEcCtD
Alosetron—Cough—Irinotecan—stomach cancer	0.000854	0.00162	CcSEcCtD
Alosetron—Hyperglycaemia—Capecitabine—stomach cancer	0.000848	0.0016	CcSEcCtD
Alosetron—Hypertension—Irinotecan—stomach cancer	0.000845	0.0016	CcSEcCtD
Alosetron—Jaundice—Docetaxel—stomach cancer	0.000844	0.0016	CcSEcCtD
Alosetron—Eczema—Epirubicin—stomach cancer	0.000843	0.00159	CcSEcCtD
Alosetron—Depression—Capecitabine—stomach cancer	0.000836	0.00158	CcSEcCtD
Alosetron—Discomfort—Irinotecan—stomach cancer	0.000823	0.00156	CcSEcCtD
Alosetron—Jaundice—Capecitabine—stomach cancer	0.000817	0.00155	CcSEcCtD
Alosetron—Urinary tract infection—Capecitabine—stomach cancer	0.000815	0.00154	CcSEcCtD
Alosetron—Confusional state—Irinotecan—stomach cancer	0.000805	0.00152	CcSEcCtD
Alosetron—Myalgia—Fluorouracil—stomach cancer	0.000798	0.00151	CcSEcCtD
Alosetron—Infection—Irinotecan—stomach cancer	0.000794	0.0015	CcSEcCtD
Alosetron—Discomfort—Fluorouracil—stomach cancer	0.000789	0.00149	CcSEcCtD
Alosetron—Haemoglobin—Docetaxel—stomach cancer	0.000781	0.00148	CcSEcCtD
Alosetron—Eczema—Doxorubicin—stomach cancer	0.00078	0.00148	CcSEcCtD
Alosetron—Haemorrhage—Docetaxel—stomach cancer	0.000777	0.00147	CcSEcCtD
Alosetron—Hepatitis—Docetaxel—stomach cancer	0.000777	0.00147	CcSEcCtD
Alosetron—Hypoglycaemia—Epirubicin—stomach cancer	0.000777	0.00147	CcSEcCtD
Alosetron—Hypoaesthesia—Docetaxel—stomach cancer	0.000773	0.00146	CcSEcCtD
Alosetron—Hyperhidrosis—Irinotecan—stomach cancer	0.000772	0.00146	CcSEcCtD
Alosetron—Confusional state—Fluorouracil—stomach cancer	0.000771	0.00146	CcSEcCtD
Alosetron—Infection—Fluorouracil—stomach cancer	0.00076	0.00144	CcSEcCtD
Alosetron—Haemoglobin—Capecitabine—stomach cancer	0.000756	0.00143	CcSEcCtD
Alosetron—Haemorrhage—Capecitabine—stomach cancer	0.000753	0.00142	CcSEcCtD
Alosetron—Hepatitis—Capecitabine—stomach cancer	0.000753	0.00142	CcSEcCtD
Alosetron—Hypoaesthesia—Capecitabine—stomach cancer	0.000749	0.00142	CcSEcCtD
Alosetron—Hypoglycaemia—Doxorubicin—stomach cancer	0.000718	0.00136	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000697	0.00132	CcSEcCtD
Alosetron—Arrhythmia—Docetaxel—stomach cancer	0.000694	0.00131	CcSEcCtD
Alosetron—Abdominal pain upper—Epirubicin—stomach cancer	0.000692	0.00131	CcSEcCtD
Alosetron—Fatigue—Irinotecan—stomach cancer	0.000689	0.0013	CcSEcCtD
Alosetron—Alopecia—Docetaxel—stomach cancer	0.000687	0.0013	CcSEcCtD
Alosetron—Pain—Irinotecan—stomach cancer	0.000683	0.00129	CcSEcCtD
Alosetron—Constipation—Irinotecan—stomach cancer	0.000683	0.00129	CcSEcCtD
Alosetron—Nasopharyngitis—Epirubicin—stomach cancer	0.000678	0.00128	CcSEcCtD
Alosetron—Arrhythmia—Capecitabine—stomach cancer	0.000672	0.00127	CcSEcCtD
Alosetron—Abdominal discomfort—Methotrexate—stomach cancer	0.000671	0.00127	CcSEcCtD
Alosetron—Gastritis—Epirubicin—stomach cancer	0.000671	0.00127	CcSEcCtD
Alosetron—Alanine aminotransferase increased—Epirubicin—stomach cancer	0.000668	0.00126	CcSEcCtD
Alosetron—Alopecia—Capecitabine—stomach cancer	0.000665	0.00126	CcSEcCtD
Alosetron—Abdominal distension—Epirubicin—stomach cancer	0.000659	0.00125	CcSEcCtD
Alosetron—Feeling abnormal—Irinotecan—stomach cancer	0.000658	0.00124	CcSEcCtD
Alosetron—Pain—Fluorouracil—stomach cancer	0.000654	0.00124	CcSEcCtD
Alosetron—Muscle spasms—Docetaxel—stomach cancer	0.000651	0.00123	CcSEcCtD
Alosetron—Upper respiratory tract infection—Methotrexate—stomach cancer	0.00065	0.00123	CcSEcCtD
Alosetron—Flatulence—Capecitabine—stomach cancer	0.000646	0.00122	CcSEcCtD
Alosetron—Abdominal pain upper—Doxorubicin—stomach cancer	0.00064	0.00121	CcSEcCtD
Alosetron—Feeling abnormal—Fluorouracil—stomach cancer	0.00063	0.00119	CcSEcCtD
Alosetron—Muscle spasms—Capecitabine—stomach cancer	0.00063	0.00119	CcSEcCtD
Alosetron—Nasopharyngitis—Doxorubicin—stomach cancer	0.000627	0.00119	CcSEcCtD
Alosetron—Depression—Methotrexate—stomach cancer	0.000622	0.00118	CcSEcCtD
Alosetron—Gastritis—Doxorubicin—stomach cancer	0.000621	0.00117	CcSEcCtD
Alosetron—Alanine aminotransferase increased—Doxorubicin—stomach cancer	0.000618	0.00117	CcSEcCtD
Alosetron—Tremor—Capecitabine—stomach cancer	0.000614	0.00116	CcSEcCtD
Alosetron—Abdominal distension—Doxorubicin—stomach cancer	0.00061	0.00115	CcSEcCtD
Alosetron—Upper respiratory tract infection—Epirubicin—stomach cancer	0.000609	0.00115	CcSEcCtD
Alosetron—Ill-defined disorder—Capecitabine—stomach cancer	0.000608	0.00115	CcSEcCtD
Alosetron—Urticaria—Fluorouracil—stomach cancer	0.000608	0.00115	CcSEcCtD
Alosetron—Pollakiuria—Epirubicin—stomach cancer	0.000605	0.00114	CcSEcCtD
Alosetron—Sweating—Methotrexate—stomach cancer	0.000598	0.00113	CcSEcCtD
Alosetron—Hyperglycaemia—Epirubicin—stomach cancer	0.000591	0.00112	CcSEcCtD
Alosetron—Malaise—Capecitabine—stomach cancer	0.000591	0.00112	CcSEcCtD
Alosetron—Cough—Docetaxel—stomach cancer	0.00059	0.00112	CcSEcCtD
Alosetron—Hypersensitivity—Irinotecan—stomach cancer	0.000589	0.00111	CcSEcCtD
Alosetron—Hypertension—Docetaxel—stomach cancer	0.000584	0.0011	CcSEcCtD
Alosetron—Myalgia—Docetaxel—stomach cancer	0.000576	0.00109	CcSEcCtD
Alosetron—Asthenia—Irinotecan—stomach cancer	0.000573	0.00108	CcSEcCtD
Alosetron—Cough—Capecitabine—stomach cancer	0.000572	0.00108	CcSEcCtD
Alosetron—Jaundice—Epirubicin—stomach cancer	0.000569	0.00108	CcSEcCtD
Alosetron—Urinary tract infection—Epirubicin—stomach cancer	0.000568	0.00107	CcSEcCtD
Alosetron—Hypertension—Capecitabine—stomach cancer	0.000566	0.00107	CcSEcCtD
Alosetron—Hypersensitivity—Fluorouracil—stomach cancer	0.000564	0.00107	CcSEcCtD
Alosetron—Dry mouth—Docetaxel—stomach cancer	0.000563	0.00107	CcSEcCtD
Alosetron—Upper respiratory tract infection—Doxorubicin—stomach cancer	0.000563	0.00107	CcSEcCtD
Alosetron—Haemoglobin—Methotrexate—stomach cancer	0.000563	0.00106	CcSEcCtD
Alosetron—Haemorrhage—Methotrexate—stomach cancer	0.00056	0.00106	CcSEcCtD
Alosetron—Hepatitis—Methotrexate—stomach cancer	0.00056	0.00106	CcSEcCtD
Alosetron—Sweating—Epirubicin—stomach cancer	0.00056	0.00106	CcSEcCtD
Alosetron—Pollakiuria—Doxorubicin—stomach cancer	0.00056	0.00106	CcSEcCtD
Alosetron—Myalgia—Capecitabine—stomach cancer	0.000558	0.00105	CcSEcCtD
Alosetron—Confusional state—Docetaxel—stomach cancer	0.000557	0.00105	CcSEcCtD
Alosetron—Anxiety—Capecitabine—stomach cancer	0.000556	0.00105	CcSEcCtD
Alosetron—Discomfort—Capecitabine—stomach cancer	0.000551	0.00104	CcSEcCtD
Alosetron—Infection—Docetaxel—stomach cancer	0.000549	0.00104	CcSEcCtD
Alosetron—Sinusitis—Epirubicin—stomach cancer	0.000548	0.00104	CcSEcCtD
Alosetron—Hyperglycaemia—Doxorubicin—stomach cancer	0.000547	0.00103	CcSEcCtD
Alosetron—Dry mouth—Capecitabine—stomach cancer	0.000545	0.00103	CcSEcCtD
Alosetron—Confusional state—Capecitabine—stomach cancer	0.000539	0.00102	CcSEcCtD
Alosetron—Skin disorder—Docetaxel—stomach cancer	0.000536	0.00101	CcSEcCtD
Alosetron—Infection—Capecitabine—stomach cancer	0.000531	0.001	CcSEcCtD
Alosetron—Haemoglobin—Epirubicin—stomach cancer	0.000527	0.000996	CcSEcCtD
Alosetron—Jaundice—Doxorubicin—stomach cancer	0.000527	0.000996	CcSEcCtD
Alosetron—Urinary tract infection—Doxorubicin—stomach cancer	0.000525	0.000993	CcSEcCtD
Alosetron—Haemorrhage—Epirubicin—stomach cancer	0.000524	0.000991	CcSEcCtD
Alosetron—Hepatitis—Epirubicin—stomach cancer	0.000524	0.000991	CcSEcCtD
Alosetron—Hypoaesthesia—Epirubicin—stomach cancer	0.000522	0.000986	CcSEcCtD
Alosetron—Skin disorder—Capecitabine—stomach cancer	0.000519	0.000982	CcSEcCtD
Alosetron—Sweating—Doxorubicin—stomach cancer	0.000518	0.00098	CcSEcCtD
Alosetron—Hyperhidrosis—Capecitabine—stomach cancer	0.000517	0.000977	CcSEcCtD
Alosetron—Vomiting—Irinotecan—stomach cancer	0.000508	0.00096	CcSEcCtD
Alosetron—Sinusitis—Doxorubicin—stomach cancer	0.000507	0.000959	CcSEcCtD
Alosetron—Rash—Irinotecan—stomach cancer	0.000504	0.000952	CcSEcCtD
Alosetron—Dermatitis—Irinotecan—stomach cancer	0.000503	0.000952	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000503	0.000951	CcSEcCtD
Alosetron—Headache—Irinotecan—stomach cancer	0.0005	0.000946	CcSEcCtD
Alosetron—Alopecia—Methotrexate—stomach cancer	0.000495	0.000936	CcSEcCtD
Alosetron—Haemoglobin—Doxorubicin—stomach cancer	0.000488	0.000922	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000487	0.000921	CcSEcCtD
Alosetron—Vomiting—Fluorouracil—stomach cancer	0.000486	0.00092	CcSEcCtD
Alosetron—Hepatitis—Doxorubicin—stomach cancer	0.000485	0.000917	CcSEcCtD
Alosetron—Haemorrhage—Doxorubicin—stomach cancer	0.000485	0.000917	CcSEcCtD
Alosetron—Hypoaesthesia—Doxorubicin—stomach cancer	0.000483	0.000913	CcSEcCtD
Alosetron—Rash—Fluorouracil—stomach cancer	0.000482	0.000912	CcSEcCtD
Alosetron—Dermatitis—Fluorouracil—stomach cancer	0.000482	0.000911	CcSEcCtD
Alosetron—Headache—Fluorouracil—stomach cancer	0.000479	0.000906	CcSEcCtD
Alosetron—Fatigue—Docetaxel—stomach cancer	0.000476	0.0009	CcSEcCtD
Alosetron—Nausea—Irinotecan—stomach cancer	0.000474	0.000897	CcSEcCtD
Alosetron—Pain—Docetaxel—stomach cancer	0.000472	0.000893	CcSEcCtD
Alosetron—Constipation—Docetaxel—stomach cancer	0.000472	0.000893	CcSEcCtD
Alosetron—Arrhythmia—Epirubicin—stomach cancer	0.000468	0.000886	CcSEcCtD
Alosetron—Alopecia—Epirubicin—stomach cancer	0.000463	0.000876	CcSEcCtD
Alosetron—Fatigue—Capecitabine—stomach cancer	0.000461	0.000872	CcSEcCtD
Alosetron—Constipation—Capecitabine—stomach cancer	0.000457	0.000865	CcSEcCtD
Alosetron—Pain—Capecitabine—stomach cancer	0.000457	0.000865	CcSEcCtD
Alosetron—Feeling abnormal—Docetaxel—stomach cancer	0.000455	0.00086	CcSEcCtD
Alosetron—Nausea—Fluorouracil—stomach cancer	0.000454	0.000859	CcSEcCtD
Alosetron—Ill-defined disorder—Methotrexate—stomach cancer	0.000452	0.000856	CcSEcCtD
Alosetron—Flatulence—Epirubicin—stomach cancer	0.00045	0.00085	CcSEcCtD
Alosetron—Feeling abnormal—Capecitabine—stomach cancer	0.000441	0.000833	CcSEcCtD
Alosetron—Malaise—Methotrexate—stomach cancer	0.00044	0.000832	CcSEcCtD
Alosetron—Muscle spasms—Epirubicin—stomach cancer	0.000439	0.00083	CcSEcCtD
Alosetron—Arrhythmia—Doxorubicin—stomach cancer	0.000433	0.000819	CcSEcCtD
Alosetron—Alopecia—Doxorubicin—stomach cancer	0.000429	0.000811	CcSEcCtD
Alosetron—Cough—Methotrexate—stomach cancer	0.000426	0.000805	CcSEcCtD
Alosetron—Urticaria—Capecitabine—stomach cancer	0.000425	0.000803	CcSEcCtD
Alosetron—Ill-defined disorder—Epirubicin—stomach cancer	0.000423	0.000801	CcSEcCtD
Alosetron—Flatulence—Doxorubicin—stomach cancer	0.000416	0.000787	CcSEcCtD
Alosetron—Myalgia—Methotrexate—stomach cancer	0.000415	0.000785	CcSEcCtD
Alosetron—Malaise—Epirubicin—stomach cancer	0.000412	0.000778	CcSEcCtD
Alosetron—Discomfort—Methotrexate—stomach cancer	0.00041	0.000776	CcSEcCtD
Alosetron—Hypersensitivity—Docetaxel—stomach cancer	0.000407	0.000769	CcSEcCtD
Alosetron—Muscle spasms—Doxorubicin—stomach cancer	0.000406	0.000768	CcSEcCtD
Alosetron—Confusional state—Methotrexate—stomach cancer	0.000401	0.000759	CcSEcCtD
Alosetron—Cough—Epirubicin—stomach cancer	0.000398	0.000753	CcSEcCtD
Alosetron—Asthenia—Docetaxel—stomach cancer	0.000396	0.000749	CcSEcCtD
Alosetron—Infection—Methotrexate—stomach cancer	0.000395	0.000748	CcSEcCtD
Alosetron—Hypertension—Epirubicin—stomach cancer	0.000394	0.000745	CcSEcCtD
Alosetron—Hypersensitivity—Capecitabine—stomach cancer	0.000394	0.000745	CcSEcCtD
Alosetron—Ill-defined disorder—Doxorubicin—stomach cancer	0.000392	0.000741	CcSEcCtD
Alosetron—Myalgia—Epirubicin—stomach cancer	0.000389	0.000735	CcSEcCtD
Alosetron—Anxiety—Epirubicin—stomach cancer	0.000387	0.000732	CcSEcCtD
Alosetron—Skin disorder—Methotrexate—stomach cancer	0.000387	0.000731	CcSEcCtD
Alosetron—Hyperhidrosis—Methotrexate—stomach cancer	0.000385	0.000728	CcSEcCtD
Alosetron—Discomfort—Epirubicin—stomach cancer	0.000384	0.000726	CcSEcCtD
Alosetron—Asthenia—Capecitabine—stomach cancer	0.000384	0.000725	CcSEcCtD
Alosetron—Malaise—Doxorubicin—stomach cancer	0.000381	0.00072	CcSEcCtD
Alosetron—Dry mouth—Epirubicin—stomach cancer	0.00038	0.000719	CcSEcCtD
Alosetron—Confusional state—Epirubicin—stomach cancer	0.000376	0.00071	CcSEcCtD
Alosetron—Infection—Epirubicin—stomach cancer	0.00037	0.0007	CcSEcCtD
Alosetron—Cough—Doxorubicin—stomach cancer	0.000368	0.000697	CcSEcCtD
Alosetron—Hypertension—Doxorubicin—stomach cancer	0.000365	0.000689	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000363	0.000686	CcSEcCtD
Alosetron—Skin disorder—Epirubicin—stomach cancer	0.000362	0.000684	CcSEcCtD
Alosetron—Hyperhidrosis—Epirubicin—stomach cancer	0.00036	0.000681	CcSEcCtD
Alosetron—Myalgia—Doxorubicin—stomach cancer	0.000359	0.00068	CcSEcCtD
Alosetron—Anxiety—Doxorubicin—stomach cancer	0.000358	0.000677	CcSEcCtD
Alosetron—Discomfort—Doxorubicin—stomach cancer	0.000355	0.000672	CcSEcCtD
Alosetron—Dry mouth—Doxorubicin—stomach cancer	0.000352	0.000665	CcSEcCtD
Alosetron—Vomiting—Docetaxel—stomach cancer	0.000351	0.000664	CcSEcCtD
Alosetron—Rash—Docetaxel—stomach cancer	0.000348	0.000658	CcSEcCtD
Alosetron—Dermatitis—Docetaxel—stomach cancer	0.000348	0.000658	CcSEcCtD
Alosetron—Confusional state—Doxorubicin—stomach cancer	0.000347	0.000657	CcSEcCtD
Alosetron—Headache—Docetaxel—stomach cancer	0.000346	0.000654	CcSEcCtD
Alosetron—Fatigue—Methotrexate—stomach cancer	0.000343	0.000649	CcSEcCtD
Alosetron—Infection—Doxorubicin—stomach cancer	0.000342	0.000647	CcSEcCtD
Alosetron—Pain—Methotrexate—stomach cancer	0.00034	0.000644	CcSEcCtD
Alosetron—Vomiting—Capecitabine—stomach cancer	0.00034	0.000643	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000339	0.000642	CcSEcCtD
Alosetron—Rash—Capecitabine—stomach cancer	0.000337	0.000637	CcSEcCtD
Alosetron—Dermatitis—Capecitabine—stomach cancer	0.000337	0.000637	CcSEcCtD
Alosetron—Headache—Capecitabine—stomach cancer	0.000335	0.000633	CcSEcCtD
Alosetron—Skin disorder—Doxorubicin—stomach cancer	0.000335	0.000633	CcSEcCtD
Alosetron—Hyperhidrosis—Doxorubicin—stomach cancer	0.000333	0.00063	CcSEcCtD
Alosetron—Nausea—Docetaxel—stomach cancer	0.000328	0.00062	CcSEcCtD
Alosetron—Feeling abnormal—Methotrexate—stomach cancer	0.000328	0.00062	CcSEcCtD
Alosetron—Fatigue—Epirubicin—stomach cancer	0.000321	0.000607	CcSEcCtD
Alosetron—Pain—Epirubicin—stomach cancer	0.000319	0.000602	CcSEcCtD
Alosetron—Constipation—Epirubicin—stomach cancer	0.000319	0.000602	CcSEcCtD
Alosetron—Nausea—Capecitabine—stomach cancer	0.000318	0.000601	CcSEcCtD
Alosetron—Urticaria—Methotrexate—stomach cancer	0.000316	0.000598	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000314	0.000594	CcSEcCtD
Alosetron—Feeling abnormal—Epirubicin—stomach cancer	0.000307	0.00058	CcSEcCtD
Alosetron—Fatigue—Doxorubicin—stomach cancer	0.000297	0.000562	CcSEcCtD
Alosetron—Urticaria—Epirubicin—stomach cancer	0.000296	0.00056	CcSEcCtD
Alosetron—Pain—Doxorubicin—stomach cancer	0.000295	0.000557	CcSEcCtD
Alosetron—Constipation—Doxorubicin—stomach cancer	0.000295	0.000557	CcSEcCtD
Alosetron—Hypersensitivity—Methotrexate—stomach cancer	0.000293	0.000554	CcSEcCtD
Alosetron—Asthenia—Methotrexate—stomach cancer	0.000286	0.00054	CcSEcCtD
Alosetron—Feeling abnormal—Doxorubicin—stomach cancer	0.000284	0.000537	CcSEcCtD
Alosetron—Hypersensitivity—Epirubicin—stomach cancer	0.000274	0.000519	CcSEcCtD
Alosetron—Urticaria—Doxorubicin—stomach cancer	0.000274	0.000518	CcSEcCtD
Alosetron—Asthenia—Epirubicin—stomach cancer	0.000267	0.000505	CcSEcCtD
Alosetron—Hypersensitivity—Doxorubicin—stomach cancer	0.000254	0.00048	CcSEcCtD
Alosetron—Vomiting—Methotrexate—stomach cancer	0.000253	0.000479	CcSEcCtD
Alosetron—Rash—Methotrexate—stomach cancer	0.000251	0.000475	CcSEcCtD
Alosetron—Dermatitis—Methotrexate—stomach cancer	0.000251	0.000474	CcSEcCtD
Alosetron—Headache—Methotrexate—stomach cancer	0.000249	0.000471	CcSEcCtD
Alosetron—Asthenia—Doxorubicin—stomach cancer	0.000247	0.000468	CcSEcCtD
Alosetron—Vomiting—Epirubicin—stomach cancer	0.000237	0.000448	CcSEcCtD
Alosetron—Nausea—Methotrexate—stomach cancer	0.000236	0.000447	CcSEcCtD
Alosetron—Rash—Epirubicin—stomach cancer	0.000235	0.000444	CcSEcCtD
Alosetron—Dermatitis—Epirubicin—stomach cancer	0.000235	0.000444	CcSEcCtD
Alosetron—Headache—Epirubicin—stomach cancer	0.000233	0.000441	CcSEcCtD
Alosetron—Nausea—Epirubicin—stomach cancer	0.000221	0.000418	CcSEcCtD
Alosetron—Vomiting—Doxorubicin—stomach cancer	0.000219	0.000414	CcSEcCtD
Alosetron—Rash—Doxorubicin—stomach cancer	0.000217	0.000411	CcSEcCtD
Alosetron—Dermatitis—Doxorubicin—stomach cancer	0.000217	0.000411	CcSEcCtD
Alosetron—Headache—Doxorubicin—stomach cancer	0.000216	0.000408	CcSEcCtD
Alosetron—Nausea—Doxorubicin—stomach cancer	0.000205	0.000387	CcSEcCtD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—stomach cancer	6.05e-05	0.00175	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—stomach cancer	6.05e-05	0.00175	CbGpPWpGaD
Alosetron—CYP1A2—Arachidonic acid metabolism—PTGS2—stomach cancer	5.97e-05	0.00173	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—stomach cancer	5.94e-05	0.00172	CbGpPWpGaD
Alosetron—CYP1A2—Metapathway biotransformation—AKR1C3—stomach cancer	5.87e-05	0.0017	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—stomach cancer	5.76e-05	0.00167	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—stomach cancer	5.58e-05	0.00162	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GMPR2—stomach cancer	5.47e-05	0.00158	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PPAP2A—stomach cancer	5.34e-05	0.00155	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	5.23e-05	0.00152	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—stomach cancer	5.03e-05	0.00146	CbGpPWpGaD
Alosetron—CYP2C9—Biological oxidations—GSTP1—stomach cancer	5.02e-05	0.00145	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—SUCLG1—stomach cancer	5e-05	0.00145	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—IDH3B—stomach cancer	5e-05	0.00145	CbGpPWpGaD
Alosetron—CYP2C9—Metapathway biotransformation—GSTP1—stomach cancer	4.95e-05	0.00143	CbGpPWpGaD
Alosetron—HTR3A—Transmembrane transport of small molecules—ALB—stomach cancer	4.92e-05	0.00142	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—GSTT1—stomach cancer	4.78e-05	0.00138	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—CYP2A6—stomach cancer	4.72e-05	0.00137	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—NDUFV1—stomach cancer	4.65e-05	0.00135	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—NDUFS1—stomach cancer	4.65e-05	0.00135	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor—MYC—stomach cancer	4.63e-05	0.00134	CbGpPWpGaD
Alosetron—CYP2C9—Biological oxidations—GSTM1—stomach cancer	4.61e-05	0.00134	CbGpPWpGaD
Alosetron—CYP2C9—Metapathway biotransformation—GSTM1—stomach cancer	4.55e-05	0.00132	CbGpPWpGaD
Alosetron—CYP3A4—Metapathway biotransformation—AKR1C3—stomach cancer	4.53e-05	0.00131	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—stomach cancer	4.53e-05	0.00131	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—stomach cancer	4.53e-05	0.00131	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—stomach cancer	4.53e-05	0.00131	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	4.47e-05	0.0013	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ACAD8—stomach cancer	4.32e-05	0.00125	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—stomach cancer	4.31e-05	0.00125	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor—TNF—stomach cancer	4.31e-05	0.00125	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—GSTP1—stomach cancer	4.29e-05	0.00124	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—stomach cancer	4.28e-05	0.00124	CbGpPWpGaD
Alosetron—CYP1A2—Metapathway biotransformation—GSTP1—stomach cancer	4.23e-05	0.00123	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	4.22e-05	0.00122	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PGLS—stomach cancer	4.15e-05	0.0012	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—BLVRB—stomach cancer	4.15e-05	0.0012	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	3.97e-05	0.00115	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PPAP2A—stomach cancer	3.95e-05	0.00115	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—GSTM1—stomach cancer	3.94e-05	0.00114	CbGpPWpGaD
Alosetron—CYP1A2—Metapathway biotransformation—GSTM1—stomach cancer	3.89e-05	0.00113	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GMPR2—stomach cancer	3.85e-05	0.00111	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	3.71e-05	0.00108	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ACAD8—stomach cancer	3.69e-05	0.00107	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—RORA—stomach cancer	3.67e-05	0.00106	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—stomach cancer	3.63e-05	0.00105	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	3.61e-05	0.00104	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CKB—stomach cancer	3.52e-05	0.00102	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CA1—stomach cancer	3.52e-05	0.00102	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—FBP1—stomach cancer	3.52e-05	0.00102	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—NDUFA2—stomach cancer	3.52e-05	0.00102	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—IDH3B—stomach cancer	3.52e-05	0.00102	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—SUCLG1—stomach cancer	3.52e-05	0.00102	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	3.39e-05	0.000982	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PLIN2—stomach cancer	3.31e-05	0.00096	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—GSTP1—stomach cancer	3.31e-05	0.000959	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GMPR2—stomach cancer	3.29e-05	0.000952	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—NDUFS1—stomach cancer	3.27e-05	0.000947	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—NDUFV1—stomach cancer	3.27e-05	0.000947	CbGpPWpGaD
Alosetron—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	3.27e-05	0.000946	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CA2—stomach cancer	3.22e-05	0.000934	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	3.2e-05	0.000926	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	3.17e-05	0.000919	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PGAM1—stomach cancer	3.14e-05	0.00091	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—NT5E—stomach cancer	3.14e-05	0.00091	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—RORA—stomach cancer	3.14e-05	0.000908	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—GSTM1—stomach cancer	3.04e-05	0.000881	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—SUCLG1—stomach cancer	3.01e-05	0.000871	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—IDH3B—stomach cancer	3.01e-05	0.000871	CbGpPWpGaD
Alosetron—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	3e-05	0.000869	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PLCE1—stomach cancer	3e-05	0.000868	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ALDH7A1—stomach cancer	3e-05	0.000868	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PGLS—stomach cancer	2.92e-05	0.000844	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—BLVRB—stomach cancer	2.92e-05	0.000844	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—UMPS—stomach cancer	2.87e-05	0.000832	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ACAD8—stomach cancer	2.85e-05	0.000825	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—NDUFS1—stomach cancer	2.8e-05	0.00081	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—NDUFV1—stomach cancer	2.8e-05	0.00081	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PPAP2A—stomach cancer	2.78e-05	0.000806	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	2.73e-05	0.000791	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	2.68e-05	0.000775	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PDHA1—stomach cancer	2.67e-05	0.000774	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ECHS1—stomach cancer	2.67e-05	0.000774	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GMPR2—stomach cancer	2.54e-05	0.000735	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—TYMP—stomach cancer	2.51e-05	0.000727	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—FADS1—stomach cancer	2.51e-05	0.000727	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—BLVRB—stomach cancer	2.49e-05	0.000722	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PGLS—stomach cancer	2.49e-05	0.000722	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CA1—stomach cancer	2.48e-05	0.000718	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—NDUFA2—stomach cancer	2.48e-05	0.000718	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—FBP1—stomach cancer	2.48e-05	0.000718	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CKB—stomach cancer	2.48e-05	0.000718	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PPAP2A—stomach cancer	2.38e-05	0.000688	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—SREBF2—stomach cancer	2.35e-05	0.000681	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PLIN2—stomach cancer	2.33e-05	0.000675	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—RORA—stomach cancer	2.32e-05	0.000673	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—IDH3B—stomach cancer	2.32e-05	0.000672	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—SUCLG1—stomach cancer	2.32e-05	0.000672	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	2.29e-05	0.000662	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CA2—stomach cancer	2.27e-05	0.000657	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PGAM1—stomach cancer	2.21e-05	0.00064	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—NT5E—stomach cancer	2.21e-05	0.00064	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ALDOB—stomach cancer	2.18e-05	0.000631	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—NDUFS1—stomach cancer	2.16e-05	0.000625	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—NDUFV1—stomach cancer	2.16e-05	0.000625	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—NDUFA2—stomach cancer	2.12e-05	0.000614	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—FBP1—stomach cancer	2.12e-05	0.000614	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CA1—stomach cancer	2.12e-05	0.000614	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CKB—stomach cancer	2.12e-05	0.000614	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ALDH7A1—stomach cancer	2.11e-05	0.000611	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PLCE1—stomach cancer	2.11e-05	0.000611	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ALOX5—stomach cancer	2.02e-05	0.000586	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—UMPS—stomach cancer	2.02e-05	0.000585	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PLIN2—stomach cancer	1.99e-05	0.000577	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—DPYD—stomach cancer	1.99e-05	0.000577	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CA2—stomach cancer	1.94e-05	0.000561	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—BLVRB—stomach cancer	1.92e-05	0.000557	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PGLS—stomach cancer	1.92e-05	0.000557	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—NT5E—stomach cancer	1.89e-05	0.000547	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PGAM1—stomach cancer	1.89e-05	0.000547	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PDHA1—stomach cancer	1.88e-05	0.000544	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ECHS1—stomach cancer	1.88e-05	0.000544	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PPAP2A—stomach cancer	1.83e-05	0.000531	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ALDH7A1—stomach cancer	1.8e-05	0.000522	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PLCE1—stomach cancer	1.8e-05	0.000522	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—FADS1—stomach cancer	1.77e-05	0.000512	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—TYMP—stomach cancer	1.77e-05	0.000512	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GSTT1—stomach cancer	1.76e-05	0.00051	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CYP2A6—stomach cancer	1.74e-05	0.000504	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—UMPS—stomach cancer	1.73e-05	0.0005	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—AKR1C3—stomach cancer	1.69e-05	0.00049	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—SREBF2—stomach cancer	1.65e-05	0.000479	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ENO1—stomach cancer	1.65e-05	0.000478	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—NDUFA2—stomach cancer	1.64e-05	0.000474	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—FBP1—stomach cancer	1.64e-05	0.000474	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CKB—stomach cancer	1.64e-05	0.000474	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CA1—stomach cancer	1.64e-05	0.000474	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—RORA—stomach cancer	1.63e-05	0.000473	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ECHS1—stomach cancer	1.61e-05	0.000465	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PDHA1—stomach cancer	1.61e-05	0.000465	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PLIN2—stomach cancer	1.54e-05	0.000445	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ALDOB—stomach cancer	1.53e-05	0.000444	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—TYMP—stomach cancer	1.51e-05	0.000437	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—FADS1—stomach cancer	1.51e-05	0.000437	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CA2—stomach cancer	1.5e-05	0.000433	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CD44—stomach cancer	1.46e-05	0.000424	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—NT5E—stomach cancer	1.46e-05	0.000422	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PGAM1—stomach cancer	1.46e-05	0.000422	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.44e-05	0.000418	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.44e-05	0.000417	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ALOX5—stomach cancer	1.42e-05	0.000412	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—SREBF2—stomach cancer	1.41e-05	0.000409	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—DPYD—stomach cancer	1.4e-05	0.000406	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—RORA—stomach cancer	1.4e-05	0.000405	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PLCE1—stomach cancer	1.39e-05	0.000403	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ALDH7A1—stomach cancer	1.39e-05	0.000403	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—UMPS—stomach cancer	1.33e-05	0.000386	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ALDOB—stomach cancer	1.31e-05	0.000379	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.27e-05	0.000368	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PPP2R1A—stomach cancer	1.24e-05	0.00036	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PDHA1—stomach cancer	1.24e-05	0.000359	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ECHS1—stomach cancer	1.24e-05	0.000359	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GSTT1—stomach cancer	1.24e-05	0.000359	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.23e-05	0.000357	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.23e-05	0.000357	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CYP2A6—stomach cancer	1.22e-05	0.000355	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GSTP1—stomach cancer	1.22e-05	0.000354	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ALOX5—stomach cancer	1.22e-05	0.000352	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—HMOX1—stomach cancer	1.2e-05	0.000349	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—DPYD—stomach cancer	1.2e-05	0.000347	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—AKR1C3—stomach cancer	1.19e-05	0.000345	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—TYMP—stomach cancer	1.17e-05	0.000337	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—FADS1—stomach cancer	1.17e-05	0.000337	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ENO1—stomach cancer	1.16e-05	0.000336	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.14e-05	0.000331	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—TYMS—stomach cancer	1.13e-05	0.000329	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GSTM1—stomach cancer	1.12e-05	0.000325	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—SREBF2—stomach cancer	1.09e-05	0.000316	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.09e-05	0.000314	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—RORA—stomach cancer	1.08e-05	0.000312	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTT1—stomach cancer	1.06e-05	0.000307	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ERCC2—stomach cancer	1.05e-05	0.000305	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CYP2A6—stomach cancer	1.05e-05	0.000303	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CD44—stomach cancer	1.03e-05	0.000298	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—AKR1C3—stomach cancer	1.02e-05	0.000295	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ALDOB—stomach cancer	1.01e-05	0.000293	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	9.99e-06	0.000289	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ENO1—stomach cancer	9.92e-06	0.000287	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—MTHFR—stomach cancer	9.91e-06	0.000287	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	9.76e-06	0.000283	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ALOX5—stomach cancer	9.39e-06	0.000272	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—DPYD—stomach cancer	9.24e-06	0.000268	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CAV1—stomach cancer	9.14e-06	0.000265	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—APOA1—stomach cancer	9.12e-06	0.000264	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CD44—stomach cancer	8.8e-06	0.000255	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PPP2R1A—stomach cancer	8.75e-06	0.000254	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GSTP1—stomach cancer	8.59e-06	0.000249	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	8.54e-06	0.000247	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—HMOX1—stomach cancer	8.47e-06	0.000245	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTT1—stomach cancer	8.17e-06	0.000237	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CYP2A6—stomach cancer	8.08e-06	0.000234	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PPARG—stomach cancer	8.04e-06	0.000233	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—TYMS—stomach cancer	7.98e-06	0.000231	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GSTM1—stomach cancer	7.89e-06	0.000229	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—AKR1C3—stomach cancer	7.86e-06	0.000228	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ENO1—stomach cancer	7.66e-06	0.000222	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PPP2R1A—stomach cancer	7.48e-06	0.000217	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ERCC2—stomach cancer	7.42e-06	0.000215	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTP1—stomach cancer	7.34e-06	0.000213	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—HMOX1—stomach cancer	7.24e-06	0.00021	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ALB—stomach cancer	7.23e-06	0.000209	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—MTHFR—stomach cancer	6.97e-06	0.000202	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—NOS3—stomach cancer	6.91e-06	0.0002	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—TYMS—stomach cancer	6.82e-06	0.000198	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CD44—stomach cancer	6.79e-06	0.000197	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTM1—stomach cancer	6.74e-06	0.000195	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CAV1—stomach cancer	6.43e-06	0.000186	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—APOA1—stomach cancer	6.42e-06	0.000186	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ERCC2—stomach cancer	6.34e-06	0.000184	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PTGS2—stomach cancer	6.32e-06	0.000183	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	6.15e-06	0.000178	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—MTHFR—stomach cancer	5.96e-06	0.000173	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PPP2R1A—stomach cancer	5.77e-06	0.000167	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTP1—stomach cancer	5.66e-06	0.000164	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PPARG—stomach cancer	5.66e-06	0.000164	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—HMOX1—stomach cancer	5.59e-06	0.000162	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CAV1—stomach cancer	5.5e-06	0.000159	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—APOA1—stomach cancer	5.48e-06	0.000159	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—TYMS—stomach cancer	5.27e-06	0.000152	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	5.25e-06	0.000152	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTM1—stomach cancer	5.2e-06	0.000151	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ALB—stomach cancer	5.09e-06	0.000147	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ERCC2—stomach cancer	4.89e-06	0.000142	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—NOS3—stomach cancer	4.86e-06	0.000141	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PPARG—stomach cancer	4.83e-06	0.00014	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—MTHFR—stomach cancer	4.6e-06	0.000133	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PTGS2—stomach cancer	4.45e-06	0.000129	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ALB—stomach cancer	4.35e-06	0.000126	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CAV1—stomach cancer	4.24e-06	0.000123	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—APOA1—stomach cancer	4.23e-06	0.000123	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—NOS3—stomach cancer	4.16e-06	0.00012	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PIK3CA—stomach cancer	3.89e-06	0.000113	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PTGS2—stomach cancer	3.8e-06	0.00011	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PPARG—stomach cancer	3.73e-06	0.000108	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ALB—stomach cancer	3.35e-06	9.71e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—NOS3—stomach cancer	3.21e-06	9.29e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PTGS2—stomach cancer	2.93e-06	8.5e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PIK3CA—stomach cancer	2.74e-06	7.93e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PIK3CA—stomach cancer	2.34e-06	6.77e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.81e-06	5.23e-05	CbGpPWpGaD
